AzTrials
AzTrials

Asthma, Allergies and ObesityNCT01229787

The Relation Between Obesity, Adipose Tissue Content of Fatty Acids and Systemic and Airway Inflammation

An observational study of Asthma, Allergies and Obesity, run by Cyprus International Institute for Environment and Public Health at 1 site in Cyprus.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Obesity has been recognized as a risk factors for developing asthma. In a cohort of 5384 children aged 15-17, we aim to: 1. To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and BMI at age 11-12 years Part II 2. Read more about this study

Who is it for?
Ages 15 to 17 yearsHealthy volunteers can take part
Conditions the study is for
Asthma, Allergies and Obesity
How many people
5,384 participants
Where
1 siteCyprus
Study dates
Jan 2007to Dec 2009
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 17 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Part I took place in 2007 and children 15-16 and 16-17 years across Cyprus were invited to participate. The targeted population were 19849 children that participated in an earlier study in years 2001-3 and had anthropometric measurements, assessment of cardio-respiratory fitness and serum lipids taken at that time. The subjects of the second part of the study were selected from the 5384 subjects that had participated in the first part and had matched data on current and past BMI. We targeted subjects for part two of the study with the following criteria:1. Current Wheezers: All active asthmatics across all BMI subgroups. Definition of Current Wheezer: Positive answer to the question in ISAAC questionnaire: "Have you had wheezing in the past 12 months?" 2. Never Wheezers: 700 controls selected in a random way across all BMI groups. Definition of Never Wheezer: Negative answers to both of the following two questions: "Have you ever had wheezing?" and "Have you ever had asthma?"

Who may be able to join

  • not applicable

Who cannot join

  • not applicable

Trial locations and contacts

1 site in 1 country.

Cyprus1 site
  • Cyprus International insitute

    Nicosia, Nicosia

Other trials in Cyprus

About this study

Obesity has been recognized as a risk factors for developing asthma. In a cohort of 5384 children aged 15-17, we aim to:

  1. To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and BMI at age 11-12 years Part II
  2. To investigate the association of BMI in adolescence and BMI at age 11-12 years with:
  3. Prevalence of allergic sensitization
  4. Lung function
  5. Levels of airway inflammation at age 16-18 years
  6. Severity of asthma

Secondly, to assess diet and physical activity involvement as effect modifiers in these possible associations.

Read the detailed description

Cross-sectional studies in Northern America, Northern Europe and Asia indicate an increased prevalence and severity of asthma in the obese whereas longitudinal studies have indicated that increasing BMI is associated with increased risk of incident asthma in women. However, the mechanisms through which where-by obesity increases the risk for asthma remain unclear. There are only few studies from North America and Asia that suggested that obesity is associated with increased skin test reactivity and atopic diseases and many more that suggest obesity has no association with atopy. In adult asthmatics, it has also been shown that both medical and surgical weight loss is consistently associated with dramatic improvements in lung function, asthma symptoms, and medication usage. However, in children no study has elaborated on the potential benefits of reducing weight.

Total fat intake has also been associated with the diagnosis of asthma. N-3 fatty acids have been noted to inversely correlate with body fat, while levels of N-6 fatty acids correlated positively with body fat. Increased dietary intake of N-3 fatty acid (such as eicosapentaenoic acid) (mainly fish oils) has been generally associated with protection from asthma, while intake of N-6 fatty acids (such as linoleic acid) may increase asthma risk, although this remains controversial. Linoleic acid may act as a precursor of arachidonic acid which subsequently serves as a precursor of 4-series leukotrienes that are highly active mediators of inflammation.

There are only two studies that investigated the levels of exhaled nitric oxide (ENO) as indicator of airway inflammation in relation with obesity and asthma. One study showed significant increase of ENO with increasing BMI in healthy adults. However, the levels of ENO and exhaled leukotriene B4 were recently found to be increased in lean and obese asthmatic children but not related to their BMI's.

In Southern European countries, there are no representative epidemiological data on the contribution of obesity to asthma burden. In this area of the world, there are also no studies on the effect of important lifestyle factors including diet and physical activity on the association of adiposity with asthma pathophysiology. In addition, no information exists on levels of airways inflammation both in non-asthmatics and asthmatics subjects in relation to body content in fat and the impact of weight reduction on airway inflammation.

In years 2001-2003, a national health survey was conducted in Cyprus focusing on nutrition and physical fitness of all children aged 11-12 years (attending the 6th form of all primary schools). With this project we proposed to approach this group of children in years 2007-2009 to investigate the following hypotheses:

AIMS:

The aims of the study are as follows:

Part I To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and independently with BMI at age 11-12 years Part II

To investigate the association of BMI at age 16-18 and independently of BMI at age 11-12 years with:

  1. Prevalence of allergic sensitization
  2. Lung function
  3. Levels of airway inflammation at age 16-18 years
  4. Severity of asthma

Secondly, to assess diet and physical activity involvement as effect modifiers in these possible associations.

PART I METHODOLOGY:

Study population Part I took place during the months of January 2007 to June 2007 and children attending the 1st (15-16 years) and 2nd (16-17 years) classes in all public and private Lyceia schools across the Republic of Cyprus were invited to participate. The targeted population were 19849 children that participated in an earlier study in years 2001-3 and had amongst other assessments anthropometric measurements, assessment of cardio-respiratory fitness and serum lipids taken at that time.

For the assessment of children's asthma status we used the Greek version of the ISAAC (International Study of Asthma and Allergies in Childhood) core questionnaire supplemented with questions relating to potential person-based risk factors such as the place of birth of the child, ethnic origin of the parents, birth order, parental education level, parental smoking, history of atopy in the immediate family (siblings and parents with a history of asthma, eczema and or hay fever), personal uptake of smoking, pet ownership and place of residence.

All participating students had also their weight, percentage body fat and Body Mass Index (BMI) measured. The subjects' BMI had been classified as normal weight, overweight or obese according to sex and age specific cut-offs (six months intervals), suggested by the International Obesity Task Force (IOTF).

Compilation of Dataset

An effort to match subjects on the 2007 cross-sectional database with subjects on the 2001-2002 old cross-sectional database was carried out using various matching parameters. A dataset of 5384 subjects was constructed with matched BMI values in 2007 (aged 15-17 years) and in 2001-2003 (aged 11-12 years).

Statistical Analysis

Using answers to the basic questions for asthma and respiratory morbidity of the ISAAC questionnaire the case definition was further refined to:

  1. Active asthma: positive answers to questions on ever having asthma and current wheeze and or night time cough unrelated to colds in the past 12 months
  2. Inactive asthma: positive answer to question on ever having asthma and negative answers to questions for current wheeze and night time cough unrelated to colds in the past 12 months
  3. Respiratory symptoms without asthma: negative answer to question on ever having asthma and positive answer(s) to questions on current wheeze and or night time cough unrelated to colds in the past 12 months.

The associations between disease outcomes and obesity predictors (BMI z-score and body fat %), were analyzed through univariate analysis and the odds ratio (OR) were calculated with 95% confidence intervals (CI). In addition to the univariate analysis, multiple logistic regression was also performed to further investigate the associations of obesity predictors and disease outcomes adjusting for confounders and stratifying by significant effect modifiers. Statistical significance was set at P < 0.05.

Keywords
asthma, allergies, obesity
Medical subject headings
Asthma, Hypersensitivity, Obesity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The association between asthma prevalence in adolescence and obsity in adolescence and in childhood

    To investigate the association of asthma prevalence at age 15-17 with body mass index (BMI) at age 15-17 and at age 11-12 years

Secondary outcomes (1)
  1. Association of BMI in adolescence and in childhood with allergic sensitization and lung function

    To investigate the association of BMI in adolescence and BMI at age 11-12 years with:

    1. Prevalence of allergic sensitization
    2. Lung function
    3. Levels of airway inflammation at age 16-18 years
    4. Severity of asthma

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2010 (estimated)
  2. Study startJan 2007
  3. Study completionDec 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Cross-sectional
Enrolment
5,384 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01229787
Sponsor's protocol ID
CIIRespiratory1
Status last verified
Jul 2009
First submitted
27 Oct 2010
Last updated
28 Oct 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Asthma, Allergies and Obesity, run by Cyprus International Institute for Environment and Public Health at 1 site in Cyprus.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Oct 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cyprus. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The association between asthma prevalence in adolescence and obsity in adolescence and in childhood. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in